DNA Gensee Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 6
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $338K
Latest Deal Amount
  • Investors
  • 1

DNA Gensee General Information


Developer of a biotechnology platform designed to detect and precisely identify plant species present in the composition of analyzed substrates. The company's platform helps to identify the plant species that are present in raw materials, ingredients, or final products, leveraging its genetic analyses, enabling users to it uses molecular biological facilities in order to provide blind analyses on highly processed products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 17, rue du lac Saint André
  • BP 90 342
  • 73377 Le Bourget du Lac cedex
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DNA Gensee Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 07-Jun-2016 $338K 00000 00.000 Completed Generating Revenue
2. Debt - General Completed Generating Revenue
1. Early Stage VC 24-Dec-2014 Completed Generating Revenue
To view DNA Gensee’s complete valuation and funding history, request access »

DNA Gensee Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 000.00 000.00 000.00 00.000
Ordinary 0,000 00.000000
Ordinary 20,000 $1.125340
To view DNA Gensee’s complete cap table history, request access »

DNA Gensee Executive Team (1)

Name Title Board Seat Contact Info
Nicole Giraud Ph.D Founder, President and Chief Executive Officer
To view DNA Gensee’s complete executive team members history, request access »

DNA Gensee Board Members (2)

Name Representing Role Since
Chloé Cohen-Aknine Starquest Capital Board Member 000 0000
Pierre Latscha Starquest Capital Board Member 000 0000
To view DNA Gensee’s complete board members history, request access »

DNA Gensee Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DNA Gensee Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Starquest Capital Venture Capital Minority 000 0000 000000 0
To view DNA Gensee’s complete investors history, request access »